Veeda Clinical Research has filed preliminary papers with SEBI to raise funds worth Rs. 831.60 crores via an initial share sale. As per the DRHP, this public issue will comprise fresh issuance of equity shares worth Rs. 331.60 crores. Moreover, it will include an offer for sale (OFS) of Rs. 500 crores. More Details Regarding …